Identifying Subgroups of Complex Patients With Cluster Analysis
Cluster analysis can aid in identifying subgroups of patients with similar patterns of comorbid conditions for targeted care management.
Cost of Post-Traumatic Stress Disorder vs Major Depressive Disorder Among Patients Covered by Medicaid or Private Insurance
Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.
Value-Based Purchasing: The Evidence
A review of evidence about what works in 3 areas of value-based purchasing emphasized under healthcare reform: service delivery integration, payment, and value-based insurance design.
Classification of Health Plans Based on Relative Resource Use and Quality of Care
This study examines variation among health plans in resource use and quality of care for patients with diabetes mellitus or cardiovascular disease.
Lynch Syndrome Screening Implementation: Business Analysis by a Healthcare System
This study synthesized published evidence on Lynch syndrome screening and expanded that evidence to match the decision needs of internal decision makers.
The FLU-FIT Program: An Effective Colorectal Cancer Screening Program for High Volume Flu Shot Clinics
Offering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.
Diabetes and Employment Productivity: Does Diabetes Management Matter?
Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.
Accountable Care Organizations: The Proposed Regulations and the Prospects for Success
CMS recently proposed regulations for Accountable Care Organizations which are extensive and complex. This article reviews the proposed regulations and discusses the prospects for success.
Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients
Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL.
HCV Screening Practices and Prevalence in an MCO, 2000-2007
HCV screening and prevalence estimates, unadjusted and adjusted for HCV risk factors, are examined in this 8-year observational study of a managed care organization.
2 Clarke Drive Cranbury, NJ 08512